Polymyxin B
Product Images NDC 45932-0030

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Polymyxin B (NDC 45932-0030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xellia Pharmaceuticals Aps, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Polymyxin (Polymyxin Carton)

Packaging label for POLYMYXIN B for Injection, USP by Xellia Pharmaceuticals ApS. The label highlights 500,000 units per vial of Polymyxin B Sulfate, lyophilized and sterile, in a package of 10 sterile vials. It includes usage warnings, storage instructions, and specifies hospital use only for intramuscular, intravenous, and intrathecal administration.*

FDA Label Image

Polymyxin (Polymyxin Image1)

Chemical structure diagram of Polymyxin B, showing the molecular configurations of Polymyxin B1 and Polymyxin B2, including amino acid sequences and notation of sulfate presence (xH2SO4).*

FDA Label Image

Polymyxin (Polymyxin Label)

Label for POLYMYXIN B for Injection, USP by Xellia Pharmaceuticals ApS. Each vial contains 500,000 units per vial of Polymyxin B Sulfate. The label includes warnings about neuro- and nephrotoxicity, instructions for hospital use only, storage conditions before and after reconstitution, and manufacturing details. Package is sterile and lyophilized, for Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.